Using a Delphi process to determine optimal care for patients with pancreatic cancer

E.A. Burmeister, S.J. Jordan, D.L. O’connell, V.L. Beesley, D. Goldstein, H.M. Gooden, M. Janda, N.D. Merrett, D. Wyld, R.E. Neale, P.H. Cosman, A. Bullen, M. Burge, M. Eastgate, Jennifer Powell, M. Deuble, D. Pryor, J. Whelan, L. Algie, S. Gupta & 24 others S.V. Lynch, B.H. Burmeister, K. Slater, David Fletcher, Guy Van Hazel, S. Raftopoulos, N. Spry, M. Agar, F. Brecciaroli, S. Caird, D. Cameron, P. Chan, L. Chantrill, D. Christie, Y.J. Chua, J. Croese, M. Cronk, J. Gani, P. Grimison, G. Hruby, M. Jefford, N. Merrett, J.S. Samra, A.P. Wysocki

    Research output: Contribution to journalArticle

    5 Citations (Scopus)

    Abstract

    © 2016 John Wiley & Sons Australia, LtdAim: Overall 5-year survival for pancreatic cancer is ~5%. Optimizing the care that pancreatic cancer patients receive may be one way of improving outcomes. The objective of this study was to establish components of care which Australian health professionals believe important to optimally manage patients with pancreatic cancer. Methods: Using a Delphi process, a multidisciplinary panel of 250 health professionals were invited to provide a list of factors they considered important for optimal care of pancreatic cancer patients. They were then asked to score and then rescore (from one [no importance/disagree] to 10 [very important/agree]) the factors. The mean and coefficient of variation scores were calculated and categorized into three levels of importance. Results: Overall, 63 (66% of those sent the final questionnaire; 25% of those initially invited) health professionals from nine disciplines completed the final scoring of 55 statements/factors encompassing themes of presentation/staging, surgery and biliary obstruction, multidisciplinary team details and oncology. Mean scores ranged from 3.7 to 9.7 with the highest related to communication and patient assessment. There was substantial intra- and interdisciplinary variation in views about MDT membership and roles. Conclusion: Overall, the opinions of Australian health professionals reflect international guideline recommended care; however, they identified a number of additional factors focusing on where patients should be treated, the importance of clear communication and the need for multidisciplinary care which were not included in current clinical practice guidelines. Differences in priorities between specialty groups were also identified.
    Original languageEnglish
    Pages (from-to)105-114
    JournalAsia-Pacific Journal of Clinical Oncology
    Volume12
    Issue number2
    DOIs
    Publication statusPublished - 2016

    Fingerprint

    Pancreatic Neoplasms
    Patient Care
    Health
    Interdisciplinary Communication
    Nuclear Family
    Practice Guidelines
    Communication
    Guidelines
    Survival

    Cite this

    Burmeister, E. A., Jordan, S. J., O’connell, D. L., Beesley, V. L., Goldstein, D., Gooden, H. M., ... Wysocki, A. P. (2016). Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia-Pacific Journal of Clinical Oncology, 12(2), 105-114. https://doi.org/10.1111/ajco.12450
    Burmeister, E.A. ; Jordan, S.J. ; O’connell, D.L. ; Beesley, V.L. ; Goldstein, D. ; Gooden, H.M. ; Janda, M. ; Merrett, N.D. ; Wyld, D. ; Neale, R.E. ; Cosman, P.H. ; Bullen, A. ; Burge, M. ; Eastgate, M. ; Powell, Jennifer ; Deuble, M. ; Pryor, D. ; Whelan, J. ; Algie, L. ; Gupta, S. ; Lynch, S.V. ; Burmeister, B.H. ; Slater, K. ; Fletcher, David ; Van Hazel, Guy ; Raftopoulos, S. ; Spry, N. ; Agar, M. ; Brecciaroli, F. ; Caird, S. ; Cameron, D. ; Chan, P. ; Chantrill, L. ; Christie, D. ; Chua, Y.J. ; Croese, J. ; Cronk, M. ; Gani, J. ; Grimison, P. ; Hruby, G. ; Jefford, M. ; Merrett, N. ; Samra, J.S. ; Wysocki, A.P. / Using a Delphi process to determine optimal care for patients with pancreatic cancer. In: Asia-Pacific Journal of Clinical Oncology. 2016 ; Vol. 12, No. 2. pp. 105-114.
    @article{aede04b42bd44236b179499db6e2b79d,
    title = "Using a Delphi process to determine optimal care for patients with pancreatic cancer",
    abstract = "{\circledC} 2016 John Wiley & Sons Australia, LtdAim: Overall 5-year survival for pancreatic cancer is ~5{\%}. Optimizing the care that pancreatic cancer patients receive may be one way of improving outcomes. The objective of this study was to establish components of care which Australian health professionals believe important to optimally manage patients with pancreatic cancer. Methods: Using a Delphi process, a multidisciplinary panel of 250 health professionals were invited to provide a list of factors they considered important for optimal care of pancreatic cancer patients. They were then asked to score and then rescore (from one [no importance/disagree] to 10 [very important/agree]) the factors. The mean and coefficient of variation scores were calculated and categorized into three levels of importance. Results: Overall, 63 (66{\%} of those sent the final questionnaire; 25{\%} of those initially invited) health professionals from nine disciplines completed the final scoring of 55 statements/factors encompassing themes of presentation/staging, surgery and biliary obstruction, multidisciplinary team details and oncology. Mean scores ranged from 3.7 to 9.7 with the highest related to communication and patient assessment. There was substantial intra- and interdisciplinary variation in views about MDT membership and roles. Conclusion: Overall, the opinions of Australian health professionals reflect international guideline recommended care; however, they identified a number of additional factors focusing on where patients should be treated, the importance of clear communication and the need for multidisciplinary care which were not included in current clinical practice guidelines. Differences in priorities between specialty groups were also identified.",
    author = "E.A. Burmeister and S.J. Jordan and D.L. O’connell and V.L. Beesley and D. Goldstein and H.M. Gooden and M. Janda and N.D. Merrett and D. Wyld and R.E. Neale and P.H. Cosman and A. Bullen and M. Burge and M. Eastgate and Jennifer Powell and M. Deuble and D. Pryor and J. Whelan and L. Algie and S. Gupta and S.V. Lynch and B.H. Burmeister and K. Slater and David Fletcher and {Van Hazel}, Guy and S. Raftopoulos and N. Spry and M. Agar and F. Brecciaroli and S. Caird and D. Cameron and P. Chan and L. Chantrill and D. Christie and Y.J. Chua and J. Croese and M. Cronk and J. Gani and P. Grimison and G. Hruby and M. Jefford and N. Merrett and J.S. Samra and A.P. Wysocki",
    year = "2016",
    doi = "10.1111/ajco.12450",
    language = "English",
    volume = "12",
    pages = "105--114",
    journal = "Asia–Pacific Journal of Clinical Oncology",
    issn = "1743-7555",
    publisher = "John Wiley & Sons",
    number = "2",

    }

    Burmeister, EA, Jordan, SJ, O’connell, DL, Beesley, VL, Goldstein, D, Gooden, HM, Janda, M, Merrett, ND, Wyld, D, Neale, RE, Cosman, PH, Bullen, A, Burge, M, Eastgate, M, Powell, J, Deuble, M, Pryor, D, Whelan, J, Algie, L, Gupta, S, Lynch, SV, Burmeister, BH, Slater, K, Fletcher, D, Van Hazel, G, Raftopoulos, S, Spry, N, Agar, M, Brecciaroli, F, Caird, S, Cameron, D, Chan, P, Chantrill, L, Christie, D, Chua, YJ, Croese, J, Cronk, M, Gani, J, Grimison, P, Hruby, G, Jefford, M, Merrett, N, Samra, JS & Wysocki, AP 2016, 'Using a Delphi process to determine optimal care for patients with pancreatic cancer' Asia-Pacific Journal of Clinical Oncology, vol. 12, no. 2, pp. 105-114. https://doi.org/10.1111/ajco.12450

    Using a Delphi process to determine optimal care for patients with pancreatic cancer. / Burmeister, E.A.; Jordan, S.J.; O’connell, D.L.; Beesley, V.L.; Goldstein, D.; Gooden, H.M.; Janda, M.; Merrett, N.D.; Wyld, D.; Neale, R.E.; Cosman, P.H.; Bullen, A.; Burge, M.; Eastgate, M.; Powell, Jennifer; Deuble, M.; Pryor, D.; Whelan, J.; Algie, L.; Gupta, S.; Lynch, S.V.; Burmeister, B.H.; Slater, K.; Fletcher, David; Van Hazel, Guy; Raftopoulos, S.; Spry, N.; Agar, M.; Brecciaroli, F.; Caird, S.; Cameron, D.; Chan, P.; Chantrill, L.; Christie, D.; Chua, Y.J.; Croese, J.; Cronk, M.; Gani, J.; Grimison, P.; Hruby, G.; Jefford, M.; Merrett, N.; Samra, J.S.; Wysocki, A.P.

    In: Asia-Pacific Journal of Clinical Oncology, Vol. 12, No. 2, 2016, p. 105-114.

    Research output: Contribution to journalArticle

    TY - JOUR

    T1 - Using a Delphi process to determine optimal care for patients with pancreatic cancer

    AU - Burmeister, E.A.

    AU - Jordan, S.J.

    AU - O’connell, D.L.

    AU - Beesley, V.L.

    AU - Goldstein, D.

    AU - Gooden, H.M.

    AU - Janda, M.

    AU - Merrett, N.D.

    AU - Wyld, D.

    AU - Neale, R.E.

    AU - Cosman, P.H.

    AU - Bullen, A.

    AU - Burge, M.

    AU - Eastgate, M.

    AU - Powell, Jennifer

    AU - Deuble, M.

    AU - Pryor, D.

    AU - Whelan, J.

    AU - Algie, L.

    AU - Gupta, S.

    AU - Lynch, S.V.

    AU - Burmeister, B.H.

    AU - Slater, K.

    AU - Fletcher, David

    AU - Van Hazel, Guy

    AU - Raftopoulos, S.

    AU - Spry, N.

    AU - Agar, M.

    AU - Brecciaroli, F.

    AU - Caird, S.

    AU - Cameron, D.

    AU - Chan, P.

    AU - Chantrill, L.

    AU - Christie, D.

    AU - Chua, Y.J.

    AU - Croese, J.

    AU - Cronk, M.

    AU - Gani, J.

    AU - Grimison, P.

    AU - Hruby, G.

    AU - Jefford, M.

    AU - Merrett, N.

    AU - Samra, J.S.

    AU - Wysocki, A.P.

    PY - 2016

    Y1 - 2016

    N2 - © 2016 John Wiley & Sons Australia, LtdAim: Overall 5-year survival for pancreatic cancer is ~5%. Optimizing the care that pancreatic cancer patients receive may be one way of improving outcomes. The objective of this study was to establish components of care which Australian health professionals believe important to optimally manage patients with pancreatic cancer. Methods: Using a Delphi process, a multidisciplinary panel of 250 health professionals were invited to provide a list of factors they considered important for optimal care of pancreatic cancer patients. They were then asked to score and then rescore (from one [no importance/disagree] to 10 [very important/agree]) the factors. The mean and coefficient of variation scores were calculated and categorized into three levels of importance. Results: Overall, 63 (66% of those sent the final questionnaire; 25% of those initially invited) health professionals from nine disciplines completed the final scoring of 55 statements/factors encompassing themes of presentation/staging, surgery and biliary obstruction, multidisciplinary team details and oncology. Mean scores ranged from 3.7 to 9.7 with the highest related to communication and patient assessment. There was substantial intra- and interdisciplinary variation in views about MDT membership and roles. Conclusion: Overall, the opinions of Australian health professionals reflect international guideline recommended care; however, they identified a number of additional factors focusing on where patients should be treated, the importance of clear communication and the need for multidisciplinary care which were not included in current clinical practice guidelines. Differences in priorities between specialty groups were also identified.

    AB - © 2016 John Wiley & Sons Australia, LtdAim: Overall 5-year survival for pancreatic cancer is ~5%. Optimizing the care that pancreatic cancer patients receive may be one way of improving outcomes. The objective of this study was to establish components of care which Australian health professionals believe important to optimally manage patients with pancreatic cancer. Methods: Using a Delphi process, a multidisciplinary panel of 250 health professionals were invited to provide a list of factors they considered important for optimal care of pancreatic cancer patients. They were then asked to score and then rescore (from one [no importance/disagree] to 10 [very important/agree]) the factors. The mean and coefficient of variation scores were calculated and categorized into three levels of importance. Results: Overall, 63 (66% of those sent the final questionnaire; 25% of those initially invited) health professionals from nine disciplines completed the final scoring of 55 statements/factors encompassing themes of presentation/staging, surgery and biliary obstruction, multidisciplinary team details and oncology. Mean scores ranged from 3.7 to 9.7 with the highest related to communication and patient assessment. There was substantial intra- and interdisciplinary variation in views about MDT membership and roles. Conclusion: Overall, the opinions of Australian health professionals reflect international guideline recommended care; however, they identified a number of additional factors focusing on where patients should be treated, the importance of clear communication and the need for multidisciplinary care which were not included in current clinical practice guidelines. Differences in priorities between specialty groups were also identified.

    U2 - 10.1111/ajco.12450

    DO - 10.1111/ajco.12450

    M3 - Article

    VL - 12

    SP - 105

    EP - 114

    JO - Asia–Pacific Journal of Clinical Oncology

    JF - Asia–Pacific Journal of Clinical Oncology

    SN - 1743-7555

    IS - 2

    ER -

    Burmeister EA, Jordan SJ, O’connell DL, Beesley VL, Goldstein D, Gooden HM et al. Using a Delphi process to determine optimal care for patients with pancreatic cancer. Asia-Pacific Journal of Clinical Oncology. 2016;12(2):105-114. https://doi.org/10.1111/ajco.12450